Results 81 to 90 of about 830,210 (192)

Spectrophotometric determination of cholinesterase activity using carbamate inhibitors [PDF]

open access: yes, 2017
Charles University, Faculty o Pharmacy in Hradec Králové Department of Pharmaceutical Chemistry and Pharmaceutical Analysis Student: Ondřej Keresteš Supervisor: PharmDr. Marta Kučerová, Ph.D. Consultant: pplk. prof. RNDr.
Keresteš, Ondřej
core  

Blood Pressure Variability in Neurodegenerative Disease: Evidence From a Large‐Scale Remote Patient Monitoring Program

open access: yesThe Journal of Clinical Hypertension, Volume 28, Issue 11, November 2026.
ABSTRACT Background Blood pressure variability (BPV) is an established predictor of cardiovascular risk, yet its physiologic determinants in specific populations remain incompletely defined. Neurodegenerative diseases are associated with autonomic dysfunction that may alter blood pressure regulation.
Wesley Smith   +5 more
wiley   +1 more source

Clinical Trajectory of Late‐Onset Delusional Disorder Toward Evolving Dementia With Lewy Bodies

open access: yesPsychogeriatrics, Volume 26, Issue 6, November 2026.
ABSTRACT Recent clinical observations indicate that late‐onset psychosis can precede the onset of dementia with Lewy bodies (DLB). However, its longitudinal clinical trajectory remains poorly understood. Delusional disorder (DD) in older adults is relatively uncommon and poor insight frequently leads to refusal of psychiatric care, limiting available ...
Hiroshige Fujishiro   +7 more
wiley   +1 more source

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer

open access: yes
Cholinesterase inhibitors constitute one of few treatment options available for Alzheimer Simulation models can be used to bring together existing data and make predictions of the long-term cost effectiveness of treatment.
Linus Jonsson
core  

Design, synthesis, molecular modeling, in vitro evaluation of novel piperidine-containing hydrazone derivatives as cholinesterase inhibitors

open access: yes
In an effort to develop new and effective therapeutic agents for Alzheimer's disease, a series of hydrazone derivatives bearing piperidine rings have been designed and synthesized.
Tatar Yılmaz, Gizem   +8 more
core   +1 more source

Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment. [PDF]

open access: yesJ Alzheimers Dis
Heo RJ   +8 more
europepmc   +2 more sources

Cholinesterase inhibitors in advanced Dementia with Lewy bodies: increase or stop?

open access: yes
Introduction There is little data on stopping cholinesterase inhibitors in Dementia with Lewy bodies (DLB). Equally, it is not known if increasing the dose of cholinesterase inhibitors may help neuropsychiatric symptoms in advanced DLB.
Cousins DA   +7 more
core   +3 more sources

Cholinesterase inhibitors for Parkinson’s disease-related visual hallucinations unresponsive to atypical antipsychotics

open access: yes, 2007
Introduction: Considering lack of accepted guideline in cases of Parkinson’s disease-related visual hallucinations with poor response or intolerance to antipsychotics, and their possible cholinergic pathogenesis, the trial with cholinesterase inhibitors ...
Tomasz Sobow
core  

Home - About - Disclaimer - Privacy